Samil Pharmaceutical Co.,Ltd (KRX:000520)
South Korea
· Delayed Price · Currency is KRW 9,100.00
-290.00 (-3.09%)
Apr 29, 2026, 3:30 PM KST
KRX:000520 Revenue
In the year 2025, Samil Pharmaceutical Co.,Ltd had annual revenue of 210.25B KRW, down -4.30%. Samil Pharmaceutical Co.,Ltd had revenue of 53.00B in the quarter ending December 31, 2025, a decrease of -8.28%.
Revenue
210.25B
Revenue Growth
-4.30%
P/S Ratio
0.95
Revenue / Employee
360.64M
Employees
583
Market Cap
199.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 210.25B | -9.45B | -4.30% |
| Dec 31, 2024 | 219.70B | 23.35B | 11.89% |
| Dec 31, 2023 | 196.35B | 16.67B | 9.28% |
| Dec 31, 2022 | 179.68B | 45.43B | 33.84% |
| Dec 31, 2021 | 134.25B | 11.25B | 9.14% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jeil Pharmaceutical Co.,Ltd | 567.24B |
| SAMSUNG PHARM. Co., LTD. | 44.29B |
| REYON Pharmaceutical | 145.93B |
| JW Lifescience | 257.83B |
| Whan In Pharm | 255.21B |
| Ilyang Pharmaceutical Co.,Ltd | 272.42B |
| AptaBio Therapeutics | 3.70B |
| Suheung | 722.31B |